Stay current with cardiology research.
Structured Briefs, personalised weekly updates, and a searchable archive of clinically relevant studies from leading journals.
Featured this week
View all this weekJACC: Cardiovascular Interventions
Randomised controlled trialPulmonary vascular & VTE
Mechanical Thrombectomy Versus Anticoagulation Alone in Intermediate-High Risk Pulmonary Embolism (PE)
Computer-assisted vacuum thrombectomy (CAVT) with anticoagulation vs anticoagulation alone
Secondary endpoint
6-min walk distance · 90 days
P = 0.003
Read the Brief
European Journal of Heart Failure
Meta-analysisHeart failure
Kidney function decline, heart failure hospitalization, and the effect of empagliflozin in heart failure: an EMPEROR-pooled analysis
Empagliflozin vs placebo
Difference in estimated glomerular filtration rate (eGFR) decline (empagliflozin vs placebo)
Between-group difference, ml/min/1.73 m²/year
- in patients without events
- 0.94
- before events
- 1.09
- post-eventThe post-event difference was smaller
- 0.29
Read the Brief
EP Europace
Secondary analysisArrhythmias & EP
Potassium-Increasing Regimens in Patients at High Risk of Ventricular Arrhythmias: A Prespecified Observational Analysis of the Randomized POTCAST Trial
Controls vs MRA vs Potassium-supplements vs Combination-therapy
Primary result
Read the Brief
Just published
More in ExploreToday · 13 October
Circulation
Circulation
Multidisciplinary Approach to Antiplatelet Management in Coronary Syndromes: A Scientific Statement From the American Heart Association
Guideline or statementCoronary & ACS
Circulation
Bleeding With Asundexian Versus Placebo in Patients With Noncardioembolic Ischemic Stroke or High-Risk TIA: OCEANIC-STROKE Randomized Trial
Randomised controlled trialCoronary & ACS
Circ Cardiovasc Imaging
Impact of 18 FDG-Avidity and Immunosuppression on Idiopathic and Genetic Cardiomyopathies
Cohort studyHeart failure
Circ Popul Health Outcomes
National Survival Estimates After Surgical Repair of Congenital Heart Disease
Cohort studyCongenital